Personal information

Activities

Collapse all

Employment (7)

The University of Texas MD Anderson Cancer Center: Houston, US

2024-12-01 to present | Associate Professor (Experimental Therapeutics)
Employment
Source: Self-asserted source
Sara Zanivan

University of Glasgow: Glasgow, Glasgow, GB

2019-08-01 to 2024-11-30 | Professor
Employment
Source: Self-asserted source
Sara Zanivan

Cancer Research UK Beatson Institute: Glasgow, Glasgow, GB

2017-05 to 2024-11-30 | Senior Research Investigator (Tumour Microenvironment and Proteomics)
Employment
Source: Self-asserted source
Sara Zanivan

University of Glasgow: Glasgow, Glasgow, GB

2017-04 to 2019-07-31 | Senior Lecturer
Employment
Source: Self-asserted source
Sara Zanivan

Beatson Institute for Cancer Research: Glasgow, Glasgow, GB

2010-11 to 2017-04 | Junior Group Leader (Tumour Microenvironment & Proteomics)
Employment
Source: Self-asserted source
Sara Zanivan

Max-Planck-Institut für Biochemie: Martinsried, Bayern, DE

2007-04 to 2010-10 | Post-doctoral fellow (Proteomics and Signal Transduction)
Employment
Source: Self-asserted source
Sara Zanivan

Candiolo Cancer Institute – FPO, IRCCS: Turin, IT

2007-01 to 2007-03 | Post-doctoral fellow (Molecular Angiogenesis)
Employment
Source: Self-asserted source
Sara Zanivan

Education and qualifications (3)

Candiolo Cancer Institute, Unversity of Torino: Candiolo, IT

2002-11 to 2006-12 | PhD (Complex Systems Applied to Post-Genomic Biology)
Education
Source: Self-asserted source
Sara Zanivan

University of Torino: Turin, IT

2001-10 to 2002-09 | 1st level Master in Bioinformatics
Education
Source: Self-asserted source
Sara Zanivan

University of Torino: Turin, IT

1996-09 to 2001-09 | MSc in Biology
Education
Source: Self-asserted source
Sara Zanivan

Funding (6)

Elucidating the role of pyruvate dehydrogenase as an epigenetic switch controller in the breast cancer stroma

2020 to 2023 | Grant
Breast Cancer Now (United Kingdom, United Kingdom, GB)
GRANT_NUMBER:

20194uqPR1307
Source: Self-asserted source
Sara Zanivan

Exploring deep plasma redox-proteome profiling for early detection of HCC

2019-11 to 2020-10 | Award
Cancer Research UK (United Kingdom, United Kingdom, GB)
GRANT_NUMBER:

C40888/A29394

Source: Self-asserted source
Sara Zanivan

Tumour Microenvironment & Proteomics

2017-11 to present | Grant
Cancer Research UK (London, GB)
GRANT_NUMBER:

29800
Source: Self-asserted source
Sara Zanivan

In depth proteomic profile of mammary normal and cancer-associated fibroblasts

2012-08-13 to 2013-04-12 | Grant
Breast Cancer Now (n/a, GB)
URL: https://grants.uberresearch.com/501100007913/BCN-2012MaySP001/In-depth-proteomic-profile-of-mammary-normal-and-cancer-associated-fibroblasts
GRANT_NUMBER:

grant.BCN-2012MaySP001
Source: Self-asserted source
Sara Zanivan via DimensionsWizard

EuPA 2012 Scientific Congress NEW HORIZONS AND APPLICATIONS FOR PROTEOMICS

2012-08-01 to 2012-08-31 | Grant
Cancer Research UK (n/a, GB)
URL: https://grants.uberresearch.com/501100000289/CRUK-A15767/EuPA-2012-Scientific-Congress-NEW-HORIZONS-AND-APPLICATIONS-FOR-PROTEOMICS
GRANT_NUMBER:

grant.CRUK-A15767
Source: Self-asserted source
Sara Zanivan via DimensionsWizard

Vascular Proteomics

2010-10-01 to 2017-09-30 | Grant
Cancer Research UK (n/a, GB)
URL: https://grants.uberresearch.com/501100000289/CRUK-A12935/Vascular-Proteomics
GRANT_NUMBER:

grant.CRUK-A12935
Source: Self-asserted source
Sara Zanivan via DimensionsWizard
How many people are using ORCID?